MA40086A1 - Anti-vasa antibodies and their methods of production and use - Google Patents

Anti-vasa antibodies and their methods of production and use

Info

Publication number
MA40086A1
MA40086A1 MA40086A MA40086A MA40086A1 MA 40086 A1 MA40086 A1 MA 40086A1 MA 40086 A MA40086 A MA 40086A MA 40086 A MA40086 A MA 40086A MA 40086 A1 MA40086 A1 MA 40086A1
Authority
MA
Morocco
Prior art keywords
vasa
antibodies
methods
vasa antibodies
relates
Prior art date
Application number
MA40086A
Other languages
French (fr)
Inventor
David Weaver
Bo Zhang
Original Assignee
Ovascience Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ovascience Inc filed Critical Ovascience Inc
Priority claimed from PCT/US2015/050449 external-priority patent/WO2016044436A2/en
Publication of MA40086A1 publication Critical patent/MA40086A1/en

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La présente invention concerne des anticorps anti-vasa, en particulier des anticorps humanisés qui se lient spécifiquement à vasa avec une affinité élevée. L'invention a également trait aux séquences d'acides aminés des cdr des chaînes légères et des chaînes lourdes, ainsi qu'à des séquences consensus pour ces cdr, de ces anticorps anti-vasa. L'invention concerne également des molécules d'acide nucléique codant pour les anticorps anti-vasa, des vecteurs d'expression, des cellules hôtes, des procédés de fabrication des anticorps anti-vasa, et des procédés d'expression des anticorps anti-vasa. Enfin, l'invention porte sur des procédés d'utilisation des anticorps anti-vasa pour isoler et/ou purifier des cellules exprimant vasa.The present invention relates to anti-vasa antibodies, particularly humanized antibodies that specifically bind to vasa with high affinity. The invention also relates to the amino acid sequences of the cdr of light and heavy chains, as well as to consensus sequences for these cdr, of these anti-vasa antibodies. The invention also relates to nucleic acid molecules encoding anti-vasa antibodies, expression vectors, host cells, methods of making anti-vasa antibodies, and methods of expressing anti-vasa antibodies. . Finally, methods for using anti-vasa antibodies to isolate and / or purify vasa-expressing cells are provided.

MA40086A 2014-09-16 2015-09-16 Anti-vasa antibodies and their methods of production and use MA40086A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462051130P 2014-09-16 2014-09-16
PCT/US2015/050449 WO2016044436A2 (en) 2014-09-16 2015-09-16 Anti-vasa antibodies, and methods of production and use thereof

Publications (1)

Publication Number Publication Date
MA40086A1 true MA40086A1 (en) 2019-07-31

Family

ID=58698591

Family Applications (1)

Application Number Title Priority Date Filing Date
MA40086A MA40086A1 (en) 2014-09-16 2015-09-16 Anti-vasa antibodies and their methods of production and use

Country Status (2)

Country Link
AR (1) AR101891A1 (en)
MA (1) MA40086A1 (en)

Also Published As

Publication number Publication date
AR101891A1 (en) 2017-01-18

Similar Documents

Publication Publication Date Title
MA49599B1 (en) Antibodies specific to cd47 and pd-l1
PH12018502225A1 (en) Anti-il-33 antibodies, compositions, methods and uses thereof
EA201890866A1 (en) BINDING MOLECULES THAT INHIBIT CANCER GROWTH
MA43028B1 (en) Bispecific antibodies for pd1 and tim3
MX2018003038A (en) Thymic stromal lymphopoietin (tslp)-binding antibodies and methods of using the antibodies.
AU2016320748A8 (en) Thymic stromal lymphopoietin (TSLP)-binding antibodies and methods of using the antibodies
PH12013501652A1 (en) Anti-vegf antibodies
CA2868907C (en) Anti-hla-b*27 antibodies and uses thereof
EA201492101A1 (en) ANTIBODIES AGAINST FCRN
EA200802168A1 (en) HUMANIZED ANTIBODY TO C-KIT
WO2013173496A3 (en) Cd33 antibodies and use of same to treat cancer
MX347020B (en) Antibody against the csf-1r.
EA201891573A1 (en) CONJUGAT THERAPEUTIC ENZYMES
MX2021000708A (en) Heavy chain antibodies binding to cd19.
EA201600276A1 (en) ANTI-IL-17-ANTIBODIES, METHOD OF THEIR RECEIVING AND METHOD OF APPLICATION
EA201992756A2 (en) ANTIBODIES AGAINST CD48 AND THEIR CONJUGATES
MA47221A1 (en) Monoclonal antibody to pd-l1
PH12017500309A1 (en) Anti-vasa antibodies, and methods of production and use thereof
EA201492163A1 (en) HUMANIZED ANTIBODIES TO TRKA, CONTAINING AMINO ACID SUBSTITUTES
MX371412B (en) Anti-ccl2 and anti-loxl2 combination therapy for treatment of scleroderma.
NZ730186A (en) Humanized anti-hepcidin antibodies and uses thereof
MX2021016098A (en) Humanized antibody molecules to cd138 and uses thereof.
WO2013186630A3 (en) Humanized antibodies to ca215
MA40086A1 (en) Anti-vasa antibodies and their methods of production and use
MY197993A (en) Method for protein purification